Background: The impact of the factor associated with a hepatic duct margin positive for cancer cell invasion and how to manage post-operative patients with residual tumor-positive status are still under debate.
Methods: The association between overall survival (OS) and pathologic variables, especially for hepatic ductal margin status, determined after surgical resection for middle and distal bile duct cancer was assessed retrospectively for 57 patients from 1987 to 2007.
Results: The estimated 5-yr survival rate of all resected cases was 33.3%. Survival was impacted by R (residual tumor) status; R0 cases (n=36) had better prognosis than R1 cases (n=21, 5-yr survival rate; 44.5% vs. 0%, p<0.05). Multivariate analyses revealed that the factor associated with poor prognosis was hepatic ductal margin status (H.R. 3.27, 95% C.I. 1.003-10.663, p=0.0495).
Conclusions: In the treatment of middle and distal bile duct cancer, it is important to secure a negative ductal margin. Surgeons should make efforts to obtain a negative ductal margin. Postoperative adjuvant treatment might have a significant role in the prolongation of survival even if the patient was pathologically diagnosed as R1.
View full abstract